LogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing Conference
/PRNewswire/ -- LogicBio® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today announced that president and chief executive...